Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2009 by Office of Rare Diseases (ORD)
Sponsor:
Collaborator:
University of Chicago
Information provided by:
Office of Rare Diseases (ORD)
ClinicalTrials.gov Identifier:
NCT00004317
First received: October 18, 1999
Last updated: May 13, 2009
Last verified: May 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2030
  Estimated Primary Completion Date: December 2030 (Final data collection date for primary outcome measure)
No publications provided by Office of Rare Diseases (ORD)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):